Bronstein, Gewirtz & Grossman, LLC introduces an investigation into allegations against Zynex, Inc. (Zyxi) and encourages investors to turn

New York City, NY / Access Newswire / March 17, 2025 / Bronstein, Certainly & Grossman, LLC examines potential claims in the name of buyers of Zynex, Inc. (“Zynex” or “The Company”) (Nasdaq: Zyxi). Investors who have bought Zynex securities are encouraged to obtain additional information and support the examination by visiting the company's website: bgandg..com/zyxi.

Investigative details

On March 11, 2025, Zynex reported the fourth quarter and the full year 2024 and unveiled sales of “deficiency” in the quarter “due to slow payments of certain payers” in the quarter. Zynex also revealed that Tricare, the health program for uniformed service members, which “currently corresponds to about 20-25% of [the Company’s] The annual turnover “has temporarily suspended payments while checking previous claims.” In these messages, Zynex's share price fell by March 12, 2025 by USD 3.59 per share or 51.3%.

What's next?

If you find out about facts regarding this investigation or have bought Zynex securities, you can support this examination by visiting the company's website: bgandg.com/zyxi. You can also contact Peretz Bronstein or his customer relationship manager Nathan Miller from Bronstein, Gewirtz & Grossman, LLC: 332-239-2660

There are no costs for you

We represent investors in collective lawsuits on a eventual fee. This means that we will ask the court to refund ourselves for expenses and legal fees, usually a percentage of the entire recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized company that represents investors in collecting lawsuits for securities fraud and shareholder derivative lawsuits. Our company has recovered hundreds of million dollars for investors nationwide.

Follow us to updates to updates too LinkedInPresent XPresent Facebookor Instagram.

Lawyer advertising. Earlier results do not guarantee similar results.

contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

See the original press release on Access Newswire